CBX-12-101: A first-in-human study of CBX-12, an alphalex peptide drug conjugate (PDC) in patients with advanced or metastatic solid tumors

F. Meric-Bernstam; J. P. Eder; A. Vandross; M. Gara; S. Gayle; P. Pearson; A. DeCillis; A. Tolcher

doi:10.1016/S0959-8049(22)00823-1

CBX-12-101: A first-in-human study of CBX-12, an alphalex peptide drug conjugate (PDC) in patients with advanced or metastatic solid tumors

F. Meric-Bernstam, J. P. Eder, A. Vandross, M. Gara, S. Gayle, P. Pearson, A. DeCillis, A. Tolcher

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	S7-S8
Journal	European Journal of Cancer
Volume	174
DOIs	https://doi.org/10.1016/S0959-8049(22)00823-1
State	Published - Oct 2022
Externally published	Yes

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1016/S0959-8049(22)00823-1

Cite this

@article{65b9defb1def45e4af515e0a5dcc48cb,

title = "CBX-12-101: A first-in-human study of CBX-12, an alphalex peptide drug conjugate (PDC) in patients with advanced or metastatic solid tumors",

author = "F. Meric-Bernstam and Eder, {J. P.} and A. Vandross and M. Gara and S. Gayle and P. Pearson and A. DeCillis and A. Tolcher",

year = "2022",

month = oct,

doi = "10.1016/S0959-8049(22)00823-1",

language = "English (US)",

volume = "174",

pages = "S7--S8",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Limited",

}

TY - JOUR

T1 - CBX-12-101

T2 - A first-in-human study of CBX-12, an alphalex peptide drug conjugate (PDC) in patients with advanced or metastatic solid tumors

AU - Meric-Bernstam, F.

AU - Eder, J. P.

AU - Vandross, A.

AU - Gara, M.

AU - Gayle, S.

AU - Pearson, P.

AU - DeCillis, A.

AU - Tolcher, A.

PY - 2022/10

Y1 - 2022/10

UR - http://www.scopus.com/inward/record.url?scp=85140457859&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85140457859&partnerID=8YFLogxK

U2 - 10.1016/S0959-8049(22)00823-1

DO - 10.1016/S0959-8049(22)00823-1

M3 - Article

AN - SCOPUS:85140457859

SN - 0959-8049

VL - 174

SP - S7-S8

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -

CBX-12-101: A first-in-human study of CBX-12, an alphalex peptide drug conjugate (PDC) in patients with advanced or metastatic solid tumors

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this